Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blood-brain barrier
Biotech
Genentech pays Alector $100M for preclinical Parkinson’s asset
Genentech is committing up to $1.17 billion in milestones and tiered royalties on net sales.
Nick Paul Taylor
Oct 5, 2026 10:09am
Novartis pays Sironax $125M to acquire brain delivery platform
Sep 16, 2026 8:32am
Novartis ‘always looking’ for new ways to shuttle drugs to brain
May 28, 2026 8:44am
Voyager pauses Alzheimer's program 8 months after unveiling med
Mar 10, 2026 10:20am
Korsana crosses into crowded Alzheimer's field with $175M
Feb 18, 2026 6:00am
Insilico agrees to $66M deal to split rights for NLRP3 inhibitor
Jan 21, 2026 7:05am
